Skip to search.
 TSX Up 0.69% TSX Ventures Down 0.08%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
13.85 Up 0.51(3.82%) 11:12AM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:13.34
Open:13.79
Bid:13.99 x 300
Ask:13.99 x 100
1y Target Est:13.67
Beta:0.49
Earnings Date:May 6 - May 11 (Est.)
Day's Range:13.65 - 14.27
52wk Range:2.31 - 14.27
Volume:3,529,010
Avg Vol (3m):3,706,190
Market Cap:1.44B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 3.82%1.44B
IMGNUp 1.42%675.08M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,013.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Mar-15) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, engages in the discovery and development of cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback